End-point determination of heterogeneous formulations using inline torque measurements for a high-shear wet granulation process
Status PubMed-not-MEDLINE Jazyk angličtina Země Nizozemsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
37387778
PubMed Central
PMC10300204
DOI
10.1016/j.ijpx.2023.100188
PII: S2590-1567(23)00032-4
Knihovny.cz E-zdroje
- Klíčová slova
- End-point determination, Growth regimes, Over-granulation, Porosity, Torque, Wet granulation,
- Publikační typ
- časopisecké články MeSH
In this study, the torque profiles of heterogeneous granulation formulations with varying powder properties in terms of particle size, solubility, deformability, and wettability, were studied, and the feasibility of identifying the end-point of the granulation process for each formulation based on the torque profiles was evaluated. Dynamic median particle size (d50) and porosity were correlated to the torque measurements to understand the relationship between torque and granule properties, and to validate distinction between different granulation stages based on the torque profiles made in previous studies. Generally, the torque curves obtained from the different granulation runs in this experimental design could be categorized into two different types of torque profiles. The primary factor influencing the likelihood of producing each profile was the binder type used in the formulation. A lower viscosity, higher solubility binder resulted in a type 1 profile. Other contributing factors that affected the torque profiles include API type and impeller speed. Material properties such as the deformability and solubility of the blend formulation and the binder were identified as important factors affecting both granule growth and the type of torque profiles observed. By correlating dynamic granule properties with torque values, it was possible to determine the granulation end-point based on a pre-determined target median particle size (d50) range which corresponded to specific markers identified in the torque profiles. In type 1 torque profiles, the end-point markers corresponded to the plateau phase, whereas in type 2 torque profiles the markers were indicated by the inflection point where the slope gradient changes. Additionally, we proposed an alternative method of identification by using the first derivative of the torque values, which facilitates an easier identification of the system approaching the end-point. Overall, this study identified the effects of different variations in formulation parameters on torque profiles and granule properties and implemented an improved method of identification of granulation end-point that is not dependent on the different types of torque profiles observed.
Zobrazit více v PubMed
Belem B.R., Ferraz H.G. Rheological profile in mixer torque rheometer of samples containing furazolidone and different binders. Chem. Eng. Res. Des. 2020;160:533–539.
Bier H. Determination of the uncritical quantity of granulating liquid by power consumption measurement on planetary mixers. Pharm Ind. 1979;41:375–380.
Bouwman A., Henstra M., Hegge J., Zhang Z., Ingram A., Seville J., Frijlink H. The relation between granule size, granule stickiness, and torque in the high-shear granulation process. Pharm. Res. 2005;22:270–275. PubMed
Cavinato M., Andreato E., Bresciani M., Pignatone I., Bellazzi G., Franceschinis E., Realdon N., Canu P., Santomaso A.C. Combining formulation and process aspects for optimizing the high-shear wet granulation of common drugs. Int. J. Pharm. 2011;416(1):229–241. PubMed
Cavinato M., Bresciani M., Machin M., Bellazzi G., Canu P., Santomaso A.C. Formulation design for optimal high-shear wet granulation using on-line torque measurements. Int. J. Pharm. 2010;387(1–2):48–55. PubMed
Censi R., Martena V., Hoti E., Malaj L., Di Martino P. Sodium ibuprofen dihydrate and anhydrous: study of the dehydration and hydration mechanisms. J. Therm. Anal. Calorim. 2013;111:2009–2018.
Han S., Hong J., Luo Q., Xu H., Tan H., Wang Q., Tao J., Zhou Y., Peng L., He Y. Hygroscopicity of organic compounds as a function of organic functionality, water solubility, molecular weight, and oxidation level. Atmos. Chem. Phys. 2022;22(6):3985–4004.
Hansuld E, Briens L. 2014. A review of monitoring methods for pharmaceutical wet granulation. Int. J. Pharm. 472(1–2):192–201. PubMed
Holm P., Schaefer T., Kristensen H. Granulation in high-speed mixers Part V. Power consumption and temperature changes during granulation. Powder Technol. 1985;43(3):213–223.
Holm P., Schaefer T., Kristensen H. Granulation in high-speed mixers Part VI. Effects of process conditions on power consumption and granule growth. Powder Technol. 1985;43(3):225–233.
Iveson S.M., Litster J.D. Growth regime map for liquid-bound granules. AICHE J. 1998;44(7):1510–1518.
Iveson S.M., Litster J.D., Hapgood K., Ennis B.J. Nucleation, growth and breakage phenomena in agitated wet granulation processes: a review. Powder Technol. 2001;117(1–2):3–39.
Iveson S.M., Wauters P.A., Forrest S., Litster J.D., Meesters G.M., Scarlett B. Growth regime map for liquid-bound granules: further development and experimental validation. Powder Technol. 2001;117(1–2):83–97.
Kašpar O., Tokárová V., Oka S., Sowrirajan K., Ramachandran R., Štěpánek F. Combined UV/Vis and micro-tomography investigation of acetaminophen dissolution from granules. Int. J. Pharm. 2013;458(2):272–281. PubMed
Köster C., Pohl S., Kleinebudde P. Evaluation of binders in twin-screw wet granulation. Pharmaceutics. 2021;13(2):241. PubMed PMC
Leuenberger H., Bier H., Sucker H. Determination of the liquid requirement for a conventional granulation process. Ger Chem Eng. 1981;4:13–18.
Leuenberger H., Puchkov M., Krausbauer E., Betz G. Manufacturing pharmaceutical granules: is the granulation end-point a myth? Powder Technol. 2009;189(2):141–148.
Lin C.-Y., Wang H.-C., Hsu W.-Y., Huang A.-N., Kuo H.-P. Stage-wise characterization of the high shear granulation process by impeller torque changing rate. Adv. Powder Technol. 2019;30(8):1513–1521.
Liu B., Wang J., Zeng J., Zhao L., Wang Y., Feng Y., Du R. A review of high shear wet granulation for better process understanding, control and product development. Powder Technol. 2021;381:204–223.
Ly A., Achouri I.E., Gosselin R., Abatzoglou N. Wet granulation end point prediction using dimensionless numbers in a mixer torque rheometer: Relationship between capillary and Weber numbers and the optimal wet mass consistency. Int. J. Pharm. 2021;605 PubMed
Mackaplow M.B., Rosen L.A., Michaels J.N. Effect of primary particle size on granule growth and endpoint determination in high-shear wet granulation. Powder Technol. 2000;108(1):32–45.
Meng W., Kotamarthy L., Panikar S., Sen M., Pradhan S., Marc M., Litster J.D., Muzzio F.J., Ramachandran R. Statistical analysis and comparison of a continuous high shear granulator with a twin screw granulator: effect of process parameters on critical granule attributes and granulation mechanisms. Int. J. Pharm. 2016;513(1–2):357–375. PubMed
Nagai T., Prakongpan S. Solubility of acetaminophen in cosolvents. Chem. Pharm. Bull. 1984;32(1):340–343.
Oka S., Kašpar O., Tokárová V., Sowrirajan K., Wu H., Khan M., Muzzio F., Štěpánek F., Ramachandran R. A quantitative study of the effect of process parameters on key granule characteristics in a high shear wet granulation process involving a two component pharmaceutical blend. Adv. Powder Technol. 2015;26(1):315–322.
Otsu T., Nakamura H., Ohsaki S., Watano S., Fujiwara S., Higuchi T. Determining Optimum Water Content for Iron Ore Granulation using Agitation Torque of Wet Ore Powder. ISIJ Int. 2022;62(7):1381–1388.
Paul S., Sun C.C. The suitability of common compressibility equations for characterizing plasticity of diverse powders. Int. J. Pharm. 2017;532(1):124–130. PubMed
Rowe R.C., Sheskey P., Quinn M. Libros Digitales-Pharmaceutical Press; 2009. Handbook of Pharmaceutical Excipients.
Ryckaert A., Stauffer F., Funke A., Djuric D., Vanhoorne V., Vervaet C., De Beer T. Evaluation of torque as an in-process control for granule size during twin-screw wet granulation. Int. J. Pharm. 2021;602 PubMed
Sampat C., Kotamarthy L., Bhalode P., Chen Y., Dan A., Parvani S., Dholakia Z., Singh R., Glasser B.J., Ierapetritou M. Enabling energy-efficient manufacturing of pharmaceutical solid oral dosage forms via integrated techno-economic analysis and advanced process modeling. Journal of Advanced Manufacturing and Processing. 2022;4(4)
Sakr W.F., Ibrahim M.A., Alanazi F.K., Sakr A.A. Upgrading wet granulation monitoring from hand squeeze test to mixing torque rheometry. Saudi Pharmaceutical Journal. 2012;20(1):9–19. PubMed PMC
Schweitzer M., Pohl M., Hanna-Brown M., Nethercote P., Borman P., Hansen G., Smith K., Larew J. Implications and opportunities of applying QbD principles to analytical measurements. Pharm. Technol. 2010;34(2):52–59.
Simon L.L., Pataki H., Gr Marosi, Meemken F., Hungerbühler K., Baiker A., Tummala S., Glennon B., Kuentz M., Steele G. Assessment of recent process analytical technology (PAT) trends: a multiauthor review. Org. Process Res. Dev. 2015;19(1):3–62.
Terashita K., Watano S., Miyanami K. Determination of end-point by frequency analysis of power consumption in agitation granulation. Chem. Pharm. Bull. 1990;38(11):3120–3123.
Thapa P., Tripathi J., Jeong S.H. Recent trends and future perspective of pharmaceutical wet granulation for better process understanding and product development. Powder Technol. 2019;344:864–882.
US Food and Drug Administration. 2004. Guidance for industry, PAT-A framework for innovative pharmaceutical development, manufacturing and quality assurance. http://wwwfda gov/cder/guidance/published html.
Food U.S., Administration Drug. 2009. Guidance for Industry, Q8 (R2) Pharmaceutical Development.
Walker E.C., McGregor N.E., Chan A.S., Sims N.A. Measuring bone volume at multiple densities by micro-computed tomography. Bio-protocol. 2021;11(1):e3873. PubMed PMC
Yu L.X., Amidon G., Khan M.A., Hoag S.W., Polli J., Raju G., Woodcock J. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771–783. PubMed PMC
Yu L.X., Kopcha M. The future of pharmaceutical quality and the path to get there. Int. J. Pharm. 2017;528(1–2):354–359. PubMed